Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 168 publications
Anaplastic Thyroid Carcinoma With Kinase Gene Fusions: Report of 3 Cases With Corresponding Cytologic, Histologic, and Molecular Findings.
Journal: Diagnostic cytopathology
Published: June 22, 2026
Management of Differentiated Thyroid Cancer.
Journal: The New England journal of medicine
Published: June 17, 2026
Clinical validation of an HPV whole-genome sequencing assay for MRD detection in patients with HPV+ head and neck cancer treated with surgery.
Journal: Science translational medicine
Published: June 10, 2026
A Novel Approach to Targeting DLL3 with Tarlatamab in a Patient with Medullary Thyroid Carcinoma after Progression on Selpercatinib.
Journal: Thyroid : official journal of the American Thyroid Association
Published: May 12, 2026
Systemic Treatment of Thyroid Cancer: ASCO Guideline.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: April 01, 2026
Response to letter re: "Artificial intelligence-powered real-time multimodal model for predicting recurrence and survival in head and neck cancer: a multicenter, multinational study".
Journal: ESMO open
Published: February 18, 2026
Who Benefits and When? Applying Circulating Tumor Human Papillomavirus DNA for Human Papillomavirus-Associated Oropharyngeal Carcinoma.
Journal: JCO oncology practice
Published: January 26, 2026
Clinical validation of an HPV whole genome sequencing assay for molecular residual disease detection in HPV-associated head and neck cancer patients treated with surgery.
Journal: medRxiv : the preprint server for health sciences
Published: December 08, 2025
Landscape of Genomic Mechanisms of Resistance to Selective RET Inhibitors in RET-Altered Solid Tumors: Analysis of the RETgistry Global Consortium.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: November 17, 2025
Efficacy and safety of dabrafenib plus trametinib in adults with differentiated thyroid cancer: a randomised, double-blind, placebo-controlled, phase 3 trial.
Journal: The Lancet. Oncology
Published: November 11, 2025
Acquired On-Target Alterations Drive Clinical Resistance to p53-Y220C Reactivators.
Journal: Cancer discovery
Published: October 07, 2025
Last Updated: 09/26/2026